Table 2.
Relationship between FBP1 expression and clinicopathological characteristics of ccRCC patients.
| Variable | Total | FBP1 expression | P | |
|---|---|---|---|---|
| Low | High | |||
| Sex | ||||
| Male | 37 | 20 | 17 | 0.939 |
| Female | 17 | 9 | 8 | |
| Age (y) | ||||
| <60 | 25 | 14 | 11 | 0.753 |
| ≥60 | 29 | 15 | 14 | |
| Tumor size (cm) | ||||
| ≤7 | 34 | 13 | 21 | 0.003 |
| >7 | 20 | 16 | 4 | |
| Lymph node metastasis | ||||
| Negative | 43 | 22 | 21 | 0.459 |
| Positive | 11 | 7 | 4 | |
| Tumor grade | ||||
| Low | 37 | 16 | 21 | 0.023 |
| High | 17 | 13 | 4 | |
| Mean SUVmax | 7.56 ± 5.57 | 4.66 ± 3.08 | 0.02 | |